A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2002
10/17/2002	US20020151508 Administering therapeutically effective amount of liposomal anthracycline composition in association with therapeutically effective amount of antibody directed against extracellular domain of growth factor receptor
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002	US20020151485 Methods and compositions for modulating fertility
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151480 Identifying a compound to treat a cardiovascular disease, e.g., atherosclerosis, characterized by aberrant 10218 nucleic acid activity or expression; detecting the presence of a nucleic acid in the sample that hybridizes to the probe
10/17/2002	US20020151473 Constrained helical peptides and methods of making same
10/17/2002	US20020151462 Helicobacter pylori membrane proteins
10/17/2002	US20020151070 Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy
10/17/2002	US20020151067 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases
10/17/2002	US20020151063 Controlling apoptosis in cells; obtain cells, incubate with modulator, monitor transcriptional activity and apoptosis
10/17/2002	US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020150993 Nucleotide sequences coding polypeptide for use in the treament of apoptosis, inflammatory or autoimmune diseases
10/17/2002	US20020150990 Hepatitis C virus peptides
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150974 Polypeptide for use in the diagnosis and treatment of osteoporosis and brain disorders
10/17/2002	US20020150972 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/17/2002	US20020150964 Peptides for the activation of the immune system in humans and animals
10/17/2002	US20020150963 Map
10/17/2002	US20020150956 Novel tig
10/17/2002	US20020150924 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of prostate cancer
10/17/2002	US20020150922 Compositions and methods for the therapy and diagnosis of colon cancer
10/17/2002	US20020150908 Diagnosing and detecting cancer in mammals; obtain cells, isolate nucleotide sequences, detect hepsin nucleotide sequences, the presence of hepsin indicates hyperplasia
10/17/2002	US20020150888 Methods of screening for modulators of HIV infection
10/17/2002	US20020150883 Immunoassays for anti-HCV antibodies using antigens with conformational epitopes
10/17/2002	US20020150669 Electrospraying apparatus and method for coating particles
10/17/2002	US20020150603 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
10/17/2002	US20020150595 Antigenic preparations and the isolation of such preparations
10/17/2002	US20020150594 Modulate immunology response
10/17/2002	US20020150593 Mycoplasma vaccine
10/17/2002	US20020150591 Amplification nucleic acids
10/17/2002	US20020150590 EBV CTL epitopes
10/17/2002	US20020150589 Administering xenogeneic differentiation antigens
10/17/2002	US20020150587 Immunological polypeptides; vaccine against gramnegative bacteria
10/17/2002	US20020150586 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
10/17/2002	US20020150585 Intensify immunology response; polysaccharide complex
10/17/2002	US20020150584 Animal feeds; pneumonia vaccine
10/17/2002	US20020150581 Compositions and methods for the therapy and diagnosis of breast cancer
10/17/2002	US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002	US20020150574 Cancer diagnosis, therapy; Dna vaccine
10/17/2002	US20020150572 Methods and compositions for the treatment of psoriasis
10/17/2002	US20020150570 Anti-CCR2 antibodies and methods of use therefor
10/17/2002	US20020150559 Binding of human antigens
10/17/2002	US20020150554 Chicken interleukin-15 and uses thereof
10/17/2002	US20020150551 Protease surface treatment
10/17/2002	CA2827167A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2810326A1 Vaccine composition
10/17/2002	CA2727715A1 Vaccine composition
10/17/2002	CA2606839A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2446886A1 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002	CA2443694A1 Anti-cd19 immunotoxins
10/17/2002	CA2443405A1 Use of cd25 binding molecules in steroid-resistant patients
10/17/2002	CA2443372A1 Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides
10/17/2002	CA2443330A1 Anti-osteopontin antibody and use thereof
10/17/2002	CA2443323A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	CA2443293A1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	CA2443223A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2443039A1 Artificial chromosomes comprising ehv sequences
10/17/2002	CA2442964A1 Improved anti-inflammatory herbal composition and method of use
10/17/2002	CA2442957A1 Renal cell carcinoma tumor markers
10/17/2002	CA2442839A1 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	CA2442817A1 Implantation serine proteinases
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2442386A1 Epitope sequences
10/17/2002	CA2441499A1 Method for producing a vaccine
10/17/2002	CA2440474A1 Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment
10/17/2002	CA2439111A1 Mucosal boosting following parenteral priming
10/17/2002	CA2435528A1 Novel polypeptides and nucleic acids encoded thereby
10/16/2002	EP1249491A2 Human very long chain acyl-CoA synthase (VLCAS)-like protein and nucleic acids encoding it
10/16/2002	EP1248836A2 Hybrid cells obtainable from antigen presenting cells
10/16/2002	EP1248835A2 Genetically modified fibroblast cell
10/16/2002	EP1248813A2 Antisense antibacterial cell division composition and method
10/16/2002	EP1248804A2 Recombinant antibodies to human interleukin-1 beta
10/16/2002	EP1248803A2 Nogo receptor-mediated blockade of axonal growth
10/16/2002	EP1248800A2 Compositions and methods for therapy and diagnosis of breast cancer
10/16/2002	EP1248799A2 Chemically modified hiv envelope glycoprotein
10/16/2002	EP1248654A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules
10/16/2002	EP1248650A2 Improved dna vaccines for production-type animals
10/16/2002	EP1248649A2 Use of hemicellulose microparticles as vaccine adjuvant
10/16/2002	EP1248648A2 Vaccination against canine herpesvirus infection and vaccines
10/16/2002	EP1248647A1 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
10/16/2002	EP1248646A2 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
10/16/2002	EP1248645A1 Novel chimeric proteins and methods for using the same
10/16/2002	EP1248644A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this
10/16/2002	EP1248643A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
10/16/2002	EP1248642A1 Vegf-d/vegf-c/vegf peptidomimetic inhibitor
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP0973794B1 Netrin receptors
10/16/2002	EP0750669B1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
10/16/2002	EP0672128B1 Stem cell proliferation factor
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	EP0619742B1 Transfection of lung via aerosolized transgene delivery
10/16/2002	CN1375006A Novel compound
10/16/2002	CN1374871A FC fusion proteins for enhancing the immunogenicity of protein and piptide antigens
10/16/2002	CN1374870A Treatment of intermediate-and high-grade non-Hodgkins lymphoma with anti-CD20 antibody
10/16/2002	CN1374869A Use of CASB 616 polypeptides and polynucleotides for cancer treatment

1 ... 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 ... 1823